Skip to main content

Renal Replacement Devices: The Development of the Bioartificial Kidney

  • Chapter
Book cover Cell Encapsulation Technology and Therapeutics
  • 416 Accesses

Abstract

With the creation of artificial organ technology, the concept of replacement of failed natural organs has shifted focus from mere life-saving objectives to a broader goal to fulfill quality of life expectations. The kidney was the first solid organ whose function was approximated by a man-made synthetic device and also the first organ replaced by autologous transplantation on a long-term basis. Current organ substitution techniques for end stage renal disease (ESRD) involve either transplanting human kidneys or attempting substitution for functions of diseased kidneys through dialysis. Despite encouraging and improving results from organ transplantation, the preferred choice of substitution therapy, it is still hampered by a shortage of organs, chronic transplant loss, and a changed patient population (Hillebrand and Land 1996). Dialysis therapy only partially replaces the filtration component of renal function and is still an imperfect, intermittent, expensive, and time-consuming replacement of renal function. Dialysis also indiscriminately removes solutes, fails to substitute for renal hormonal and metabolic activities, and requires dietary restrictions and drug therapy to maintain the patient in a state of suboptimal health. The kidney is not simply a filter that produces urine as a waste product, but by monitoring and adjusting the concentrations of multiple compounds in the blood within very narrow limits, it regulates the internal environment to maintain near-perfect homeostasis. The realization that the complexity and amazing efficiency of the natural kidneys cannot be easily mimicked by man-made materials motivates work towards providing a biological component to the artificial kidney device. Hybridization, which means the combining of biological tissues with artificial hardware, is the most plausible solution to constructing “near-natural” kidneys. When such a neoartificial kidney is implanted, it will allow a continuous, increased level of filtration and will also replace the metabolic and endocrine functions “naturally.” This approach may circumvent the shortage problem posed by renal transplantations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Baldamus CA, Pollok M. 1989. Ultrafiltration and hemofiltration, practical applications in replacement of renal function by dialysis. In: Maher J, editor. 3rd ed. Boston: Kluwer Academic Publishers.

    Google Scholar 

  • Brenner BM, Hostetter TH, Humes HD. 1978. Molecular basis of proteinuria of glomerular origin. New England Journal of Medicine 298(15):826–833.

    Article  PubMed  CAS  Google Scholar 

  • Coimbra TM, Cieslinski DA, Humes HD. 1990. Epidermal growth factor accelerates renal repair in mercuric chloride nephrotoxicity. American Journal of Physiology 259:F438–F443.

    PubMed  CAS  Google Scholar 

  • Golper TA. 1985. Continuous arteriovenous hemofiltration in acute renal failure. American Journal of Kidney Diseases 6(6):373–386.

    PubMed  CAS  Google Scholar 

  • Guyton AC, Hall JE. 1997. Human physiology and mechanisms of disease. 6th ed. Philadelphia W.B. Saunders Company, p 212–230.

    Google Scholar 

  • Hillebrand G, Land W. 1996. Renal transplantation: progress and prospects. Artificial Organs 20(5):403–407.

    Article  PubMed  CAS  Google Scholar 

  • Humes HD, Cieslinski DA, Coimbra TM. 1989. Epidermal growth factor enhances renal tubule cell regeneration and repair and accelerates the recovery of renal function in postischemic acute renal failure. Journal of Clinical Investigation 84(6): 1757–1761.

    Article  PubMed  CAS  Google Scholar 

  • Humes HD, Cieslinski DA. 1992. Interaction between growth factors and retinoic acid in the induction of kidney tubulogenesis in tissue culture. Experimental Cell Research 201(1):8–1

    Article  PubMed  CAS  Google Scholar 

  • Humes HD. 1995. Tissue engineering of the kidney. In: Bronzino JD, editor. The biomedical engineering handbook. Boca Raton: CRC Press, p 1807–1824.

    Google Scholar 

  • Humes HD. 1996. Application of gene and cell therapies in the tissue engineering of a bioartificial kidney (editorial). Int J Artif Organs 19(4):215–217.

    PubMed  CAS  Google Scholar 

  • Humes HD. 1996. The bioartificial renal tubule: Prospects to improve supportive care in acute renal failure. Ren Fail 18(3):405–408.

    Article  PubMed  CAS  Google Scholar 

  • Humes HD. 1996. Tissue engineering of a bioartificial kidney: A universal donor organ. Transplant Proc 28(4):2032–2035.

    PubMed  CAS  Google Scholar 

  • Humes HD, Krauss JC, Cieslinski DA. 1996. Tubulogenesis from isolated single cells of adult mammalian kidney: Clonal analysis with a recombinant retrovirus. American Journal of Physiology 271: F42–F49.

    PubMed  CAS  Google Scholar 

  • Kramer P, Wigger W, Rieger J. 1977. Arterio-venous hemofiltration: a new and simple method for treatment of overhydrated patients resistant to diuretics. Klin Wochenschr 55:1121.

    Article  PubMed  CAS  Google Scholar 

  • Kadletz M, Magometschnigg H, Minar, E. 1992. Implantation of in vitro endothelialized polytetrafluoroethylene grafts in human beings. J Thorac Cardiovasc Surg 104:736.

    PubMed  CAS  Google Scholar 

  • Mackay S, Funke A, Buffington D, Humes HD. 1998. Tissue engineering of bioartificial renal tubule. ASAIO: 44:179–183.

    Article  CAS  Google Scholar 

  • Matsumura KN. 1978. After fifteen years: artificial liver & artificial pancreas. 2nd ed. Berkeley, CA: Alin Foundation Press.

    Google Scholar 

  • Robertson CR, Deen WM, Troy JL, Brenner BM. 1972. Dynamics of glomerular ultrafiltration in the rat. 3. Hemodynamics and autoregulation. Am J Physiol 223(5): 1191–1200.

    PubMed  CAS  Google Scholar 

  • Shepard AD, Eldrup-Jorgensen J, Keough EM. 1986. Endothelial cell seeding of small-caliber synthetic grafts in the baboon. Surgery 99:318.

    PubMed  CAS  Google Scholar 

  • Schnider PA, Hanson SR, Price TM. 1988. Durability of confluent endothelial cell monolayers of small-caliber vascular prostheses in vitro. Surgery 103:456.

    Google Scholar 

  • United States Renal Data System 1994 annual data report. Prevalence and cost of ESRD therapy. American Journal of Kidney Diseases 18(5)(supp 2):21.

    Google Scholar 

  • Wilson JM, Birinyl LK, Salomon RN. 1989. Implantation of vascular grafts lined with genetically modified endothelial cells. Science 244(4910): 1344–1346.

    Article  PubMed  CAS  Google Scholar 

  • Woods JD, Humes HD. 1997. Prospects for a bioartificial kidney. Seminars in Nephrology 17:1–6.

    Google Scholar 

  • Zwiebel JA, Freeman SM. Kantoff PW. 1989. Highlevel recombinant gene expression rabbit endothelial cells transduced by retroviral vectors. Science 243(4888):220–222.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Gautam, S., Humes, H.D. (1999). Renal Replacement Devices: The Development of the Bioartificial Kidney. In: Kühtreiber, W.M., Lanza, R.P., Chick, W.L. (eds) Cell Encapsulation Technology and Therapeutics. Birkhäuser, Boston, MA. https://doi.org/10.1007/978-1-4612-1586-8_22

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-1586-8_22

  • Publisher Name: Birkhäuser, Boston, MA

  • Print ISBN: 978-1-4612-7205-2

  • Online ISBN: 978-1-4612-1586-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics